• Hypertrophic Cardiomyopathy (HCM)
  • Eyecare
  • Urothelial Carcinoma
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Beneficiaries getting caught between a rock and a copay


If misery loves company, then Beverly Thomas of Carbondale, Ill.,isn't alone. She is one of thousands of dual eligibles(beneficiaries covered by both Medicaid and Medicare) who went tothe pharmacy after January 1, 2006, only to find that it would notfill their prescriptions. Unfortunately, her medication for mentalillness is so critical that if she misses even a day, she could behospitalized. With the help of Southern Illinois Regional SocialServices, Thomas got squared away, but admits she still is confusedabout how the new Medicare Part D benefit operates.

Everybody has a story. New York Senator Hillary Rodham Clinton related the problems of one of her constituents, a cerebral palsy patient who had been filling his critical prescriptions at the same pharmacy for years. After Part D kicked in, the drug cost him $42 because of a glitch in the system. The family pharmacist fronted the drug cost, hoping to get reimbursed.

As many as 73% of dual eligibles have an annual income below $10,000, compared with 12% for all other Medicare beneficiaries, and have twice the rate of poor health; they represent about half of current Medicaid spending, according to the Kaiser Commission on Medicaid and the Uninsured. This large group-more than 6 million-has been automatically enrolled in new Medicare Part D plans without responsibility for premiums or deductibles.

Dual eligibles, who represent about one-seventh of the 42 million total Medicare beneficiaries eligible for Part D, also are facing: copayments for the first time; little opportunity to acquire necessary drugs if they are unable to afford the copayment; no access to an emergency supply of drugs while eligibility is being checked or prior authorization approved; and no coverage for certain drugs.

Random assignment to a Prescription Drug Plan (PDP) in a beneficiary's geographic region (whose premium is at or below the benchmark for the region) often results in duals landing in a plan that does not include all of their current drugs on its formulary or does not network with their pharmacy of choice.

Although duals have the opportunity to change PDPs monthly, unlike other Medicare beneficiaries, many healthcare professionals agree that the population of duals-the poorest, sickest, least-educated and costliest to treat-will be less inclined to make a change, either because they don't understand the options or do not know how to disenroll from a plan. In addition, it may be impossible to find a plan that covers a dual eligible's needs and still falls at or below the benchmark premium amount.

Tom Paul, chief pharmacy officer for Ovations, a business unit of UnitedHealth Group that addresses the needs of members 50 years and older, strongly advocates that dual eligibles complete the process for changing plans early in the previous month so that they will be enrolled by the following month.

Despite contingency plans by the Centers for Medicare & Medicaid Services (CMS), such as a point-of-sale enrollment mechanism allowing dual eligibles who were not enrolled in Part D before its start to present evidence of Medicare and Medicaid eligibility to receive their prescriptions, the transition period in January did not proceed smoothly. The Kaiser Commission on Medicaid and the Uninsured notes that if there is an error of only 0.5%, a large number of dual eligibles will face a gap in coverage.

Last November, the Kaiser Commission, in conjunction with Health Management Associates, conducted a focus group of 12 Medicaid officials whose concerns validated what would transpire in January:

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.